Case Studies / Pharma
Eliminating $64M in Batch Failures & FDA 483 Remediation
A global pharmaceutical manufacturer faced $22M per batch failure in write-offs plus $4M each in FDA 483 observation remediation. CAPA cycles averaged 90 days with no causal link between deviations — until Causeloop traced every failure to upstream equipment calibration drift.
$22M Every Time a Batch Fails — With No Causal Link
The CAPA system had thousands of deviations open, but no intelligence connecting them. Each investigation was siloed. Every batch failure came as a complete surprise.
The CAPA Labyrinth
90-day average CAPA cycle. Root cause investigations were document-heavy, manually cross-referenced across LIMS, QMS, EBR, and maintenance systems — none of which talked to each other.
3 FDA 483 observations in 2023 — each $4M in remediation costs plus reputational exposure. The observations were for repeat deviations that had occurred 6 months earlier but were never connected.
Lyophilizer calibration drift at Site 3 caused 4 batch failures over 6 months ($88M in write-offs) before anyone realized it was the same equipment, the same drift, the same root cause.
No predictive signal. The quality team was entirely reactive — reviewing deviations after the batch was already lost, with no ability to intervene before failure.
Predictive Quality, Audit-Ready CAPAs
29-day average CAPA cycle — a 68% reduction. Causeloop auto-generates the causal chain, surfaces the affected systems, and pre-populates the CAPA document with evidence.
Zero FDA 483s in year 2. Repeat deviation patterns are now surfaced before the next audit. The manufacturer demonstrated to FDA that systemic issues were identified and resolved proactively.
Batch failure predicted 8 days early. Lyophilizer drift at Site 3 was flagged by Causeloop after the second batch — preventing batches 3 and 4 from ever being started. Saved $44M.
Cross-site deviation sharing. Causeloop identified the same lyophilizer drift pattern at Site 5 — before a single batch failed there — using the causal model from Site 3.
One Thermometer. Four Batch Failures. $88M.
The lyophilizer shelf temperature drift started at +0.3°C — well within the SPC control chart warning limits. By the time it became visible in standard QC, four batches worth $88M were already lost.
From Lyophilizer Drift to Audit-Ready CAPA
How Causeloop traced 4 batch failures to a single calibration gap — and closed it before FDA noticed.
Ingest
LIMS, QMS, EBR (electronic batch records), SCADA, and maintenance CMMS unified across all 6 manufacturing sites globally.
6 sites · real-timeDetect Deviations
LIMS anomaly in shelf temperature logged on Day 1 of the drift. Correlated to 3 prior deviations across batches PGA-4410, -4411, -4412 automatically.
Day-1 signalTrace Root Cause
Causal chain: PM schedule gap → lyophilizer calibration drift (+2.3°C) → shelf temp excursion → sterility deviation → batch failure. Cross-site pattern confirmed.
Full chain · cross-siteAuto-Generate CAPA
CAPA document pre-populated with full causal evidence, affected batches, corrective actions, and effectiveness check schedule. FDA-ready in 2 hours.
29-day cycle avgCross-Site Learning
Site 5 lyophilizer flagged using Site 3 causal model — before a single failure there. The loop is broken across the entire manufacturing network.
$44M prevented"We spent three years trying to make our CAPA process faster. Causeloop didn't speed up the process — it changed what the process does. Instead of investigating after the fact, we're now preventing the deviation from repeating. Our FDA relationship has never been better."
12 Months of Quality Intelligence
Causeloop connected all 6 manufacturing sites in 26 days. One year later, the quality team had transformed from reactive investigators to predictive guardians.
Annual savings realized
Batch failure prevention ($44M from 2 avoided failures) + CAPA labor reduction ($8M) + FDA 483 remediation avoided ($12M).
CAPA cycle reduction
From 90 days to 29 days on average. Auto-generated causal evidence packages eliminated 60% of the manual investigation work.
FDA 483 observations (year 2)
After 3 observations in 2023, the manufacturer received zero in 2024. FDA acknowledged the systemic quality improvement in the EIR.
Average batch failure lead time
Causeloop now predicts batch quality outcomes 5–12 days before the batch is released — enabling intervention before failure, not after.
Cross-site pattern sharing
Causal models from one site now automatically propagate to all 6. Site 5 avoided $22M in failures using the Site 3 lyophilizer model.
First-year ROI
At $7.6M annual platform investment, the manufacturer realized 8.4× ROI. The quality team is now expanding Causeloop to all 14 global sites.
See Your Quality Deviation Root Causes
Connect your LIMS, QMS, and EBR systems. In 48 hours, Causeloop maps the causal chains behind your open deviations — and shows you how many are the same root cause wearing different masks.